News
Combining TTFields with gemcitabine and nab-paclitaxel can improve OS in patients with locally advanced pancreatic adenocarcinoma, results of the PANOVA-3 trial suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback